Commercial Space Company Risk / Opportunity Ranking

Thesis: GalaxEye has the clearest opportunity evidence in the screen because it moved from pre-launch to an actual in-orbit milestone for Mission Drishti, described as the first OptoSAR satellite, and also has evidence of a commercialization path via an NSIL data-resale arrangement. For a 1 year+ horizon, a successful first satellite launch can support follow-on constellation buildout, data sales, and fundraising progression if commissioning and execution continue.

Why now: The key timing change is that earlier pre-launch coverage from April 23, 2026 was followed by launch coverage on May 3, 2026/May 4, 2026, and later June 16, 2026 context states the first satellite was launched in May 2026, confirming a business-state transition from concept/pre-launch to deployed asset status. The NSIL resale agreement was reported earlier on February 13, 2026, giving a potential go-to-market bridge once satellite data is available.

Caveats: Most reviewed sources rows are neutral facts or supporting article context rather than explicit positive evidence. Funding totals vary across articles (~$14.5M, $18.3M, ~$20M), so exact capitalization is uncertain

Thesis: Loft Orbital has the strongest opportunity case in this screen because multiple dated within the recent evidence window articles describe a multi-year CNES contract worth up to tens of millions of euros for a next-generation Earth observation constellation, with the first satellite scheduled for Q4 2026 or by year-end 2026. Additional 2026 context says Loft is expanding from hosted payloads into full-service 'constellations as a service,' which supports a durable 1 year+ strategic scaling thesis.

Why now: Why now is credible for a 1 year+ horizon because several dated articles from 2026 establish a recent contract win and near-forward deployment timeline: Loft announced on April 30, 2026 a multi-year CNES contract worth up to tens of millions of euros with first satellite scheduled to launch in Q4 2026. Via Satellite on May 1, 2026 described a 10-satellite EO constellation under that contract. SpaceNews on May 5, 2026 said Loft is expanding into 'full-service constellation deals'.

Caveats: Most retained support is supporting article context, which the reviewed sources treats as bounded context and weaker than direct dated event/fact evidence. Several favorable funding articles for Loft are dated January 2025 and were dropped by the 90-day recent evidence window, so they should not drive the current score. Execution risk remains around deploying the constellation and meeting the stated 2026 launch timing.

Thesis: Momentus has credible 1 year+ opportunity from recent execution milestones and commercial/government traction: Vigoride 7 launched in late March 2026, and in June 2026 the company announced a new commercial contract for Vigoride-9 in-orbit services. This supports product progression from demonstration toward revenue-bearing missions.

Why now: Why-now is supported by recent mission and contract evidence within the recent evidence window: on March 30, 2026 Momentus announced the successful launch of Vigoride 7 and called it its most advanced on-orbit demonstration campaign to date; on June 17, 2026 it announced a new commercial contract with LASP to host and operate the OWLS mission on Vigoride-9, expanding its commercial revenue portfolio.

Caveats: The SHIELD contract-vehicle selection is dated December 10, 2025 and outside the 90-day recent evidence window, so it is useful background but not a recency catalyst here. Some weak context rows repeat the same article-level claims and are not independent confirmation.

Thesis: Open Cosmos has the clearest visible operating-progress evidence in the screen. A June 17, 2026 article says it launched the first two satellites of its new Ka-band LEO telecom constellation and had secured a license from Liechtenstein a week earlier to use high-priority radio bands, indicating actual network rollout and regulatory progress toward sovereign and secure communications offerings for governments and enterprises.

Why now: The timing is favorable for a 1 year+ horizon because the latest dated evidence on June 17, 2026 indicates market entry and operation of the first telecom satellites, which can matter over a multi-quarter rollout period. A prior April 8, 2026 article also shows Open Cosmos spacecraft being used in the Orpheus UK military mission, adding defense-adjacent relevance. These dates are source dates extracted from the article summaries.

Caveats: Evidence is external article context and weak-context rows, not direct positive events. Same-article repeated rows are not independent confirmation.

Thesis: Rocket Lab has credible long-horizon opportunity from expanding beyond launch into higher-value national security satellite production and operations, while also showing continued commercial launch execution.

Why now: The main catalyst is the May 2026 award of Rocket Lab's first GEO satellite production program for the U.S. Space Force, which extends the company into a new orbital regime and broadens its mission model. That is paired with evidence of ongoing launch execution on May 22, 2026 through the ninth dedicated Electron mission for Synspective.

Caveats: The reviewed sources contain no direct negative events, so risk is mainly execution-based rather than explicitly evidenced adverse news. One representative item references stock performance but is undated and should not be treated as reliable recency proof.

Thesis: Sateliot has a solid 1 year+ opportunity setup because company-linked facts say it launched a €100 million Series C round to deploy 16 satellites for 5G IoT and direct-to-device connectivity, while later article context adds that it signed its first commercial contract for a dedicated LEO launch for two Tritó satellites in 2027. The combination of financing and launch planning supports constellation build-out potential.

Why now: The sequence matters: the company launched the Series C on April 8, 2026/April 13, 2026, then later reporting on May 21, 2026 noted a first commercial launch contract, and June 24, 2026 reporting still described the round as seeking capital and a lead investor. That mix creates both opportunity and financing risk over a 1 year+ horizon.

Caveats: The reviewed sources does not provide a direct positive event row for the first commercial contract; that support is supporting article context and weaker than a structured company event row. Later dated coverage indicates financing is still being sought, which partially offsets the opportunity thesis. Undated context items exist in the reviewed sources but are not used for recency-sensitive judgments.

Thesis: SatSure has the strongest non-Boeing opportunity setup in this screen because multiple recent article summaries indicate it secured a 246 million rupee ($2.57 million) grant from India's space regulator to develop AI-powered Earth observation models, and a later June 2026 article says Safran Electronics & Defense and SatSure signed an MoU to collaborate on GEOINT solutions for the Indian market. Together these suggest both public-sector support and ecosystem partnership momentum relevant over a 1 year+ horizon

Why now: Why now is strong because the June 11-22, 2026 evidence sequence shows fresh capital support first, then a later strategic partnership, suggesting opportunity maturation within weeks rather than stale background context

Caveats: Most evidence is supporting article context or weak context rather than direct positive events. Same-story repetition around the grant should not be treated as independent confirmation. No direct available evidence of revenue, backlog conversion, or deployment milestones.

Thesis: Starfish Space has the strongest positive evidence in the screen: recent Series B funding of more than $100 million and company-linked evidence of existing work with Space Force, NASA, and SES support a multi-year scaling thesis in on-orbit servicing.

Why now: The timing is favorable for a 1 year+ horizon because recent financing on April 7, 2026 was explicitly tied to executing first servicing missions and boosting production, following prior government contract momentum

Caveats: The strongest support is external web-search evidence, though it is company-linked and dated. Some contract details in weaker article context vary and should not be over-aggregated across repeated articles.

Thesis: TakeMe2Space has recent funding support from IN-SPACe under the Technology Adoption Fund, with the article stating selected startups will each receive up to ₹25 crore, which supports a durable financing-and-development opportunity over a 1 year+ horizon.

Why now: The IN-SPACe funding article is dated June 12, 2026, very recent within the recent evidence window, and describes first investment into selected Indian spacetech startups including TakeMe2Space, which could shape the next year of development. Source date: June 12, 2026

Caveats: Reviewed evidence notes prior broader membership support, but only one in-window article context is retained here. Evidence is supporting article context only despite stronger historical support counts.

Thesis: Turion Space has credible long-horizon opportunity because the reviewed sources show a sizable Series B closed on April 15, 2026 to accelerate deployment of its space domain awareness satellite fleet, alongside evidence that it has already launched spacecraft and is expanding a maneuverable satellite fleet for in-orbit observation missions.

Why now: The key timing driver is the dated financing round on April 15, 2026, which the reviewed sources say positions the company to scale beyond single-mission spacecraft toward a persistent SDA constellation, a development relevant over a 1 year+ horizon.

Caveats: The reviewed sources have no direct positive or negative dated events; the case relies on supporting article context rather than stronger internal company-specific events. The company website context on May 23, 2026 is weaker than independent company-specific event evidence and should not be overweighted. Citation

Thesis: Astrobase has visible funding support tied to a specific propulsion-development goal. A June 12, 2026 article says IN-SPACe selected it under the Technology Adoption Fund and that each project can receive up to ₹25 crore; the same summary says Astrobase aims to develop a high-thrust closed-cycle liquid rocket engine. For a 1 year+ horizon, non-dilutive or quasi-public funding for propulsion development is a meaningful opportunity signal.

Why now: The funding article is recent, with published June 12, 2026, and specifically notes this as IN-SPACe's first investment in Indian startups under the TAF scheme. That timing matters for a 1 year+ horizon because it may enable development progress over coming quarters.

Caveats: Visible evidence is only one external article summary despite the membership rationale referencing multiple structured support articles. No technical test results or customer contracts are provided in the exposed evidence.

Thesis: Blue Origin has meaningful long-horizon upside from multiple recent demand signals: a Space Force national security launch task order, a planned return-to-service New Glenn launch for 48 Amazon Leo satellites, and a NASA moon-base award tied to a fall 2026 target window.

Why now: The setup is active and recent: on May 30, 2026 SpaceNews reported Blue Origin received an NSSL task order hours before a New Glenn explosion, while on May 27, 2026 GeekWire reported New Glenn was preparing to return to service for an Amazon Leo mission after its first launch failure; on May 26, 2026 Investing.com summarized a NASA moon-base contract with launch no earlier than fall 2026

Caveats: Positive evidence is mostly supporting article context rather than direct events. One external article is undated and is not relied on for recency proof. Government support after the anomaly partially offsets, but does not erase, execution risk.

Thesis: ElevationSpace has one of the better opportunity setups in this screen because the reviewed sources includes a recent dated article saying it raised $40 million in Series B funding, bringing total raised to $63.5 million, for a business developing space-to-Earth transportation and a space environment utilization and recovery platform. A large recent financing can support product development and scaling over a 1 year+ horizon.

Why now: The catalyst is recent and dated: the financing article is timestamped June 19, 2026, which is inside the 90-day recent evidence window and recent enough to matter for a 1 year+ business-building horizon.

Caveats: Support is still supporting article context rather than direct positive events. Only one article is available, limiting corroboration.

Thesis: General Atomics has the clearest opportunity signal in the screen because an article dated April 8, 2026 says Space Systems Command awarded 14 companies more than $1.8 billion in Andromeda contracts for the Geosynchronous Reconnaissance & Surveillance Constellation, and General Atomics is named among the companies. For a 1 year+ horizon, inclusion in a large U.S. defense-space procurement could support durable program participation if it converts into funded work streams, though the reviewed sources only provides supporting article context rather than a direct company event row., April 8, 2026

Why now: The catalyst is recent within the reviewed sources recent evidence window: the is April 8, 2026, and it describes Space Force awarding Andromeda contracts, a potentially durable procurement cycle relevant to a 1 year+ horizon., April 8, 2026

Caveats: This is supporting article context/weak context, not a direct company event row. Same-article repeated rows in the reviewed sources are not independent confirmation.

Thesis: GITAI has the strongest opportunity setup in this screen because a dated June 16, 2026 company announcement says it completed the flight model of its S3 robotic satellite mission for an on-orbit servicing technology demonstration and framed the platform as supporting future defense-focused LEO constellation services, indicating tangible program maturation rather than just category membership.

Why now: The key catalyst is recent and inside recent evidence window: on June 16, 2026, GITAI announced completion of the S3 flight model for an on-orbit servicing demonstration mission, which is directly relevant to a 1 year+ horizon because it may precede launch, demonstration, and downstream defense/commercial adoption over the next year.

Caveats: Primary evidence is from the company itself. No retained independent customer, contract, or revenue evidence is provided. The spaceindex.io entry is undated and should not be treated as recency proof.

Thesis: Intuitive Machines has moderate long-horizon opportunity because recent Space Force selection expands its relevance beyond lunar services into space surveillance capabilities, potentially broadening its addressable defense business.

Why now: The timing case comes from May 12, 2026 reporting that Intuitive Machines was selected for the Space Force Andromeda IDIQ to develop space surveillance capabilities through 2030 and beyond, described as the company's first major selection following the Lanteris Space acquisition.

Caveats: The reviewed sources provide supporting article context but no direct structured fact with quantified contract value specific to Intuitive Machines. No direct adverse evidence is available; risk is based on competitive award structure and evidence limitations. Long-horizon upside depends on conversion from selection status into meaningful programs.

Thesis: Kepler shows a meaningful operational milestone: the company said it successfully launched the first tranche of optical relay satellites and that a 10-satellite ring marks the beginning of its operational optical data relay network. For a 1 year+ horizon, first-network deployment can support follow-on service activation and adoption.

Why now: The latest visible evidence is dated June 23, 2026, making the milestone recent within the 90-day recent evidence window. The article explicitly frames this as the beginning of an operational network, which is more relevant to a 1 year+ horizon than a short-lived announcement.

Caveats: Primary evidence is from Kepler's own site. No direct contract, revenue, or financing detail is provided in the visible evidence. Same article appears in both representative and weak-context forms, which is not independent confirmation.

Thesis: L3Harris has a moderate opportunity case from current participation in the Space Force’s Andromeda space domain awareness effort, which could support multi-year defense-space positioning. Recent article context published April 8, 2026 lists L3Harris among the companies awarded Andromeda contracts for RG-XX satellites.

Why now: The recent timing anchor is the April 8, 2026 Andromeda article. Older 2020 MOSSAIC history exists in the reviewed sources but should not drive the current timing view because it is outside the recent evidence window and materially older than the current contract context.

Caveats: Current opportunity case depends on supporting article context rather than available direct positive events. The reviewed sources includes an older 2020 contract article, but that is not recent support for 'why now'.

Thesis: Recent supporting article context indicates Lockheed Martin won a Space Force contract worth up to $105 million to modernize the GPS ground control network and support GPS IIIF operations, which supports a durable government-space revenue opportunity over a 1 year+ horizon.

Why now: The relevant contract article is dated April 16, 2026, inside the 90-day recent evidence window, and describes current modernization work tied to GPS IIIF support, which can matter over a multi-quarter horizon. Source date: April 16, 2026

Caveats: Evidence is supporting article context only; no direct positive event row is available. Same article appears in multiple weak-context rows and does not count as independent confirmation.

Thesis: Among this screen, Logos has the clearest in-recent evidence window strategic progress: it recently secured FCC approval for a very large broadband constellation of up to 4,178 satellites, which is a meaningful regulatory milestone for a long-horizon satellite communications buildout.

Why now: A dated article within the 90-day recent evidence window, with based on April 13, 2026, states that Logos Space Services recently secured FCC approval for a constellation of up to 4,178 broadband satellites and described both target customers and technical architecture, making this a timely strategic-development signal for a 1 year+ horizon.

Caveats: Evidence is supporting article context, not a richer set of direct dated events/facts. Only one article after recent evidence window; same-article repeated rows are not independent confirmation.

Thesis: No direct negative evidence is retained in the reviewed sources for KVH Industries within the selected recent evidence window.

Why now: The membership rationale says KVH appeared as a listed player in a generic defense satellite communication market report tied to article: but the reviewed sources retains zero evidence after recent evidence window and provides no, so this is too weak for a directional thesis.

Caveats: Generic market-report mention is weaker than company-specific event evidence. The support article ID is cited in the reviewed sources rationale but no article or retained evidence row is provided.

Thesis: No material adverse evidence is available. The low risk score should be interpreted as insufficient evidence, not affirmative de-risking.

Why now: Why-now is weak because no within the recent evidence window evidence are available, so timing, financing status, and launch progress cannot be judged from the current reviewed sources.

Caveats: Membership rationale references, and, but no article details are available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Potential IPO/funding relevance is mentioned only in membership rationale and cannot be elevated without direct evidence.

Thesis: No direct negative evidence is available in the reviewed sources, so no risk thesis is supportable.

Why now: The reviewed sources only describes that Intuitive Machines acquired Lanteris for about $800M via article, but provides no available evidence, no business description, and no.

Caveats: Acquisition mention without business detail is insufficient for ranking direction. No post-recent evidence window evidence are available. Referenced has no in the reviewed sources.

Thesis: No direct adverse evidence is available in the reviewed sources, and the main limitation is that Leidos appears to be a defense IT contractor rather than a core commercial space operator under these cohort rules.

Why now: No surviving evidence are available after the 90-day filter despite 300 articles considered. The rationale cites: and: but no are provided in these reviewed sources.

Caveats: Membership rationale is not direct directional proof. No retained evidence after recent evidence window. Cohort fit is ambiguous because support is infrastructure/IT modernization rather than operator economics.

Thesis: The reviewed sources does not provide direct negative evidence on LeoLabs in the available recent evidence window period, so risk scoring remains low.

Why now: No dated company-specific evidence are available after filtering, so there is no strong timing signal in these reviewed sources.

Caveats: No usable evidence after recent evidence window. Membership rationale is insufficient for a high score.

Thesis: No retained adverse evidence exists in the active recent evidence window, so only a low risk score is supportable from these reviewed sources.

Why now: The only concrete company-specific article summary says Leonardo was self-funding a 20-satellite Earth-observation constellation on February 23, 2026, but that date is older than the March 29, 2026 cutoff, so recency is insufficient for a stronger current thesis.

Caveats: The cited article is outside the 90-day recent evidence window; reviewed sources reports kept_rows 0 and dropped_rows 2. No retained positive or negative evidence exist after filtering. Article-level recap context is weaker than direct event/fact evidence.

Thesis: No retained adverse evidence is shown, so a negative thesis is likewise unsupported.

Why now: Why now is weak because 8 articles were considered but zero remained after the March 29, 2026 cutoff, leaving no current catalyst or status confirmation.

Caveats: No recent evidence window-qualified evidence. Phase-2 rationale is not enough for directional conviction.

Thesis: Insufficient retained evidence within the reviewed sources to support a material adverse thesis.

Why now: There is no available post-recent evidence window evidence for this company. The reviewed sources notes two considered articles, but zero article IDs after recent evidence window and zero evidence retained, so recency-sensitive judgment is not possible.

Caveats: The reviewed sources say support used article IDs existed earlier, but no retained evidence are available after the 90-day recent evidence window cutoff of March 29, 2026. Absence of evidence is not positive or negative proof.

Thesis: There is no direct adverse evidence in the reviewed sources; the main risk is that evidence is context-only and insufficient to assess business traction or downside.

Why now: No dated or citable event evidence is available. The reviewed sources indicates provisional single-article context tied to article id: but no or summary is provided and no evidence survived recent evidence window.

Caveats: Support level is explicitly provisional_single_article_context, which is weaker than company-specific event or fact evidence. No current evidence is provided for article: preventing direct citation. Scores remain minimal due to lack of evidence, not a strong negative view.

Thesis: No material adverse evidence is available in the reviewed sources.

Why now: There is no retained post-recent evidence window evidence row in these reviewed sources despite membership rationale referencing NASA-related wins, so timing support is insufficient.

Caveats: Membership rationale is not enough for a strong thesis without cited retained evidence. Coverage after recent evidence window is effectively zero in these reviewed sources.

Thesis: There is no direct adverse evidence in the reviewed sources within the recent evidence window; risk is scored low because the reviewed sources are evidence-empty rather than because the business is de-risked.

Why now: No within the recent evidence window company-specific catalyst or business-state change is available. Coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window, with cutoff date March 29, 2026.

Caveats: Reviewed evidence references only a profile-like article via membership rationale, not available direct evidence: but no is provided in these reviewed sources. No current source-cited evidence was found in the reviewed sources.

Thesis: There is no material adverse evidence available after recent evidence filtering; the main risk is that the company's actual role and relevance cannot be established from reviewed sources evidence.

Why now: No direct catalyst or citable business-state evidence is available. The reviewed sources references article ids: and: but provides no and no retained evidence.

Caveats: The reviewed sources explicitly says the evidence is mostly thematic/stock-basket context rather than direct business description. No or quotes are provided for direct citation.

Thesis: No material adverse thesis is supportable from the retained evidence in these reviewed sources. The low risk score reflects lack of evidence, not business quality.

Why now: Why now is weak because the reviewed sources' evidence recent evidence review shows zero kept rows after the 90-day cutoff ending March 29, 2026 and coverage data shows articles after recent evidence window of 0, so recency is not established from retained evidence.

Caveats: Phase-2 membership rationale cites but no or retained evidence row is provided in these reviewed sources, so it cannot be used for factual claims. Coverage after recent evidence window is effectively empty: evidence recent evidence review cutoff_date March 29, 2026 with kept_rows 0. Scores reflect insufficient evidence, not a fundamental bearish or bullish view.

Thesis: No material adverse thesis is supportable from the retained evidence.

Why now: Why now is weak because no evidence survived the 90-day recent evidence window in the available reviewed sources; evidence recent evidence review kept_rows is 0 and coverage data articles after recent evidence window is 0.

Caveats: Phase-2 rationale is not enough for a factual claim without and retained evidence detail. No within the recent evidence window direct evidence is available. Low scores reflect absence of usable evidence.

Thesis: No retained 90-day direct negative evidence is available to support a risk thesis.

Why now: The reviewed sources show zero retained article IDs and zero evidence after recent evidence filtering, so there is no recent company-specific evidence base for a 1 year+ directional call.

Caveats: Historical membership support references article IDs, but no post-recent evidence window evidence are served here. Low scores reflect insufficient evidence, not an evaluated business conclusion.

Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Marlan Space.

Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. Partnership context alone should not be treated as propagated operating evidence under the evidence standard.

Thesis: No material negative evidence is available; the main risk is lack of current reviewed sources evidence and classification as a supplier rather than a core space operator.

Why now: There is no surviving 90-day evidence to establish a current catalyst. The rationale references and: without in these reviewed sources.

Caveats: Supplier exposure alone is not enough for a strong positive thesis without direct, timely event evidence. No retained evidence after recent evidence window.

Thesis: No adverse evidence is present. Risk stays low because there is no material negative event in the reviewed sources.

Why now: Why now is weak because there are no representative articles or available evidence after recent evidence window, and the only support is the membership rationale referencing: without article summary details in the ranking fields.

Caveats: No representative article content is included for direct citation beyond membership rationale reference. No direct positive or negative evidence are available after recent evidence window. Scoring is constrained by sparse surfaced evidence.

Thesis: There is also insufficient direct adverse evidence; the main risk is simply that the reviewed sources' support is generic and not company-event-specific, preventing a meaningful thesis ranking.

Why now: No 'why now' is evidenced. The reviewed sources show zero post-recent evidence window available evidence despite a large article universe.

Caveats: Phase-2 rationale references: but no or summary is provided. Generic market-report mention is weaker than direct company event/fact evidence. Coverage debug shows zero evidence after recent evidence window.

Thesis: No retained direct negative evidence is provided, so the reviewed sources does not support a material adverse thesis either.

Why now: Why now is weak because despite 72 articles considered, zero article IDs and zero evidence were retained after the March 29, 2026 cutoff, preventing any current sequencing or catalyst assessment.

Caveats: No admissible post-recent evidence window evidence. Membership review rationale is contextual only and not a directional scoring basis by itself.